Moxifloxacin HCL, a fourth-generation antibiotic developed by Bayer, has created a INR 3000 crore market globally, primarily in the form of 400 mg tablets. The overall market for moxifloxacin API is approximately 150 metric tons, with most manufacturers located in India. The document also identifies potential future market projections and compares various market sizes and prices between domestic and export segments.